Evidence map›Paper›PMID 31686351›Full record

ArticleCell biology and toxicology2020

In vitro toxicological assessment of free 3-MCPD and select 3-MCPD esters on human proximal tubule HK-2 cells.

Miriam E Mossoba, Mapa S T Mapa, Magali Araujo, Yang Zhao, Brenna Flannery, Thomas Flynn, Jessica Sprando, Paddy Wiesenfeld, Robert L Sprando

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biology and toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Miriam E MossobaCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA. miriam.mossoba@fda.hhs.gov.ORCID http://orcid.org/0000-0001-6004-0280
Mapa S T MapaCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Magali AraujoCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Yang ZhaoCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Brenna FlanneryCFSAN, Office of Analytics and Outreach (OAO), Division of Risk and Decision Analysis (DRDA), Contaminant Assessment Branch (CAB), U.S. FDA, College Park, MD, 20740, USA.
Thomas FlynnCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Jessica SprandoVirginia-Maryland College of Veterinary Medicine, Blacksburg, VA, 24061, USA.
Paddy WiesenfeldCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Robert L SprandoCenter for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Applied Regulatory Toxicology (DART), Neurotoxicology and In vitro Toxicology Branch (NIVTB), MOD-1 Laboratories, U.S. Food and Drug Administration (U.S. FDA), Laurel, MD, 20708, USA.
Center for Food Safety and Applied Nutrition · USVirginia–Maryland College of Veterinary Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloropropanols are chemical contaminants that can be formed during industrial processing of foods, such as lipids used in commercially available infant and toddler formula in the USA. Many researchers have studied the most common chloropropanol contaminant, 3-monochloropropane-1,2-diol (3-MCPD), as well as its lipid ester derivatives. A plethora of toxicological outcomes have been described in vivo, including effects on the heart, nervous system, reproductive organs, and kidneys. To better understand the concordance of some of these effects to in vitro outcomes, we focused our research on using an in vitro cellular model to investigate whether the proximal tubule cells of the kidney would be vulnerable to the effects of free 3-MCPD and nine of its common esters in commercial formula. Using the established human kidney proximal tubule cell line, HK-2, we performed 24-h treatments using 3-MCPD and nine mono- or di-esters derived from palmitate, oleate, and linoleate. By directly exposing HK-2 cells at treatment doses ranging from 0 to 100 μM, we could evaluate their effects on cell viability, mitochondrial health, reactive oxygen species (ROS) production, and other endpoints of toxicity. Since chloropropanols reportedly inhibit cellular metabolism through interference with glycolysis, we also tested the extent of this mechanism. Overall, we found mild but statistically significant evidence of cytotoxicity at the highest tested treatment concentrations, which were also associated with mitochondrial dysfunction and transient perturbations in cellular metabolism. Based on these findings, further studies will be required to better understand the effects of these compounds under conditions that are more physiologically relevant to human infant and toddler proximal tubules in order to mimic their exposure to chloropropanol-containing foods.

Indexed as

alpha-ChlorohydrinCell LineEstersFatty AcidsHumansKidneyKidney Tubules, ProximalMitochondriaReactive Oxygen Speciesalpha-ChlorohydrinEstersFatty AcidsReactive Oxygen Species3-Monochloropropane-1,2-diolFatty acid estersHK-2Kidney

Identifiers

PMID31686351
OpenAlexW2987142214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.